† A Randomized Study to Compare LDL-C-Lowering Effects of Inclisiran with Usual Care vs Usual Care Alone in Patients with Recent Hospitalization for an Acute Coronary Syndrome: Rationale and Design of the VICTORION-INCEPTION trial

Patients are at high risk for a recurrent cardiovascular (CV) event in the first year following acute coronary syndrome (ACS). Low-density lipoprotein cholesterol (LDL-C) is a modifiable risk factor for recurrent CV events. Despite the availability of lipid-lowering therapies (LLT), many patients fail to achieve guideline-recommended LDL-C

Source: Journal of Clinical Lipidology - July 1, 2023 Category: Lipidology Authors: Jeffrey L Anderson, Ann Marie Navar, Neerja Balachander, Nihar R Desai, Kirk U Knowlton Tags: Novel Therapies in Lipid Management and Co-Morbidities Source Type: research